Alpha-1 adrenergic antagonists and the risk of hospitalization or death in non-hospitalized patients with COVID-19: a population-based study
Antoniou T, McCormack D, Tadrous M, Gomes T. Fundam Clin Pharmacol. 2024; Apr 4 [Epub ahead of print].
Publications
Trends in opioid toxicities among people with and without opioid use disorder and the impact of the COVID-19 pandemic in Ontario, Canada: a population-based analysis
Ledlie S, Tadrous M, Bayoumi AM, McCormack D, Cheng C, Besharah J, Munro C, Gomes T. Int J Drug Policy. 2024; Mar 23 [Epub ahead of print].
Association of virtual end-of-life care with healthcare outcomes before and during the COVID-19 pandemic: a population-based study
Lapp JM, Stukel TA, Chung H, Bell CM, Bhatia RS, Detsky AS, Downar J, Isenberg SR, Lee DS, Stall N, Tanuseputro P, Quinn KL. PLOS Digit Health. 2024; 3(3):e0000463. Epub 2024 Mar 13.
Changes in end-of-life symptom management prescribing among long-term care residents during COVID-19
Fremont D, Roberts RL, Webber C, Clarke AE, Milani C, Isenberg SR, Bush SH, Kobewka D, Turcotte L, Howard M, Boese K, Arya A, Robert B, Sinnarajah A, Simon JE, Lau J, Qureshi D, Downar J, Tanuseputro P. J Am Med Dir Assoc. 2024; Mar 1 [Epub ahead of print].
Vulnerable road user injury trends following the COVID-19 pandemic in Toronto, Canada: an interrupted time series analysis
Batomen B, Macpherson A, Lewis J, Howard A, Saunders NR, Richmond S, Harris MA, Saskin R, Zagorski B, Macarthur C, Fuselli P, Rothman L. J Safety Res. 2024; Feb 29 [Epub ahead of print].
Measuring waning protection from seasonal influenza vaccination during nine influenza seasons, Ontario, Canada, 2010/11 to 2018/19
Chung H, Campitelli MA, Buchan SA, Campigotto A, Crowcroft NS, Gubbay JB, Jung JKH, Karnauchow T, Katz K, McGeer AJ, McNally JD, Richardson DC, Richardson SE, Rosella LC, Russell ML, Schwartz KL, Simor A, Smieja M, Sundaram ME, Warshawsky BF, Zahariadis G, Kwong JC; Canadian Immunization Research Network (CIRN) Provincial Collaborative Network (PCN) Investigators. Euro Surveill. 2024; 29(8):2300239. Epub 2024 Feb 22.
A multiprovincial retrospective analysis of the incidence of myocarditis or pericarditis after mRNA vaccination compared to the incidence after SARS-CoV-2 infection
Naveed Z, Chu C, Tadrous M, Veroniki AA, Li J, Rouleau I, Febriani Y, Calzavara A, Buchan S, Nasreen S, Schwartz KL, Wilton J, Seo CY, Thampi N, Wilson S, Naus M, De Serres G, Janjua NZ, Kwong JC; Canadian Immunization Research Network (CIRN) Provincial Collaborative Network investigators. Heliyon. 2024; Feb 19 [Epub ahead of print].
Indirect impact of childhood 13-valent pneumococcal conjugate vaccine (PCV13) in Canadian older adults: a Canadian Immunization Research Network (CIRN) retrospective observational study
Nasreen S, Wang J, Marra F, Kwong JC, McGeer A, Sadarangani M, Wilson SE, Fadel SA. Thorax. 2024; Feb 15 [Epub ahead of print].
COVID-19 vaccines and adverse events of special interest: a multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals
Faksova K, Walsh D, Jiang Y, Griffin J, Phillips A, Gentile A, Kwong JC, Macartney K, Naus M, Grange Z, Escolano S, Sepulveda G, Shetty A, Pillsbury A, Sullivan C, Naveed Z, Janjua NZ, Giglio N, Perälä J, Nasreen S, Gidding H, Hovi P, Vo T, Cui F, Deng L, Cullen L, Artama M, Weintraub E, Lu H, Clothier HJ, Batty K, Paynter J, Petousis-Harris H, Buttery J, Black S, Hviid A. Vaccine. 2024; Feb 12 [Epub ahead of print].
Inequalities in access to prenatal care during the COVID-19 pandemic: analysis of a population-based cohort
Hetherington E, Darling E, Harper S, Nguyen F, Schummers L, Norman WV. Paediatr Perinat Epidemiol. 2024; Feb 10 [Epub ahead of print].